methionine methyl ester has been researched along with Cerebellar Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demaerel, P; Flamen, P; Legius, E; Mortelmans, L; Plets, C; Sciot, R; Van Calenbergh, F; Vantomme, N | 1 |
Hatazawa, J; Hori, M; Kajimoto, K; Kanai, Y; Kato, H; Kimura, Y; Kitagawa, K; Maruno, M; Oku, N; Tanaka, MR; Yoshimine, T | 1 |
2 other study(ies) available for methionine methyl ester and Cerebellar Diseases
Article | Year |
---|---|
Lhermitte-Duclos disease: 11C-methionine positron emission tomography data in 4 patients.
Topics: Adult; Amino Acids; Carbon Radioisotopes; Cerebellar Diseases; Cerebellar Neoplasms; Cerebellum; Dominance, Cerebral; Female; Granular Cell Tumor; Hamartoma Syndrome, Multiple; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Purkinje Cells; Syndrome | 2006 |
Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Adult; Aged; Brain Neoplasms; Cerebellar Diseases; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |